Nicht aus der Schweiz? Besuchen Sie lehmanns.de

ADME and Translational Pharmacokinetics / Pharmacodynamics of Therapeutic Proteins (eBook)

Applications in Drug Discovery and Development
eBook Download: EPUB
2015
John Wiley & Sons (Verlag)
978-1-118-89874-1 (ISBN)

Lese- und Medienproben

ADME and Translational Pharmacokinetics / Pharmacodynamics of Therapeutic Proteins - Honghui Zhou, Frank-Peter Theil
Systemvoraussetzungen
134,99 inkl. MwSt
(CHF 129,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
With an emphasis on the fundamental and practical aspects of ADME for therapeutic proteins, this book helps readers strategize, plan and implement translational research for biologic drugs. Details cutting-edge ADME (absorption, distribution, metabolism and excretion) and PKPD (pharmacokinetic / pharmacodynamics) modeling for biologic drugs Combines theoretical with practical aspects of ADME in biologic drug discovery and development and compares innovator biologics with biosimilar biologics and small molecules with biologics, giving a lessons-learned perspective Includes case studies about leveraging ADME to improve biologics drug development for monoclonal antibodies, fusion proteins, pegylated proteins, ADCs, bispecifics, and vaccines Presents regulatory expectations and industry perspectives for developing biologic drugs in USA, EU, and Japan Provides mechanistic insight into biodistribution and target-driven pharmacokinetics in important sites of action such as tumors and the brain

Honghui Zhou is a Senior Director and Janssen Fellow, at Janssen Research & Development, LLC and US head of Pharmacological and Translational Modeling. Board-certified by the American Board of Clinical Pharmacology and a Fellow of American Association of Pharmaceutical Scientists (AAPS) and American College of Clinical Pharmacology (ACCP), he has authored 200 peer-reviewed scientific papers, book chapters, and conference abstracts and co-edited the book Drug-Drug Interactions for Therapeutic Biologics (Wiley, 2013). Frank-Peter Theil heads nonclinical development at UCB Biopharma. Dr. Theil has authored and co-authored 40 research publications, three book chapters and he has given numerous invited presentations at national and international scientific meetings. He is a member of the American Association of Pharmaceutical Scientists (AAPS) and American Society of Clinical Pharmacology and Therapeutics (ASCPT).

"At the outset, one?s impressed with the scope of the book; it provides an outline of very diverse topics starting with the basics of protein engineering and how these are used to design and manipulate the ADME properties of recombinant and synthetic proteins...The authors have to be congratulated on their endeavor to stitch these topics together in a single book...With such a wide range of topics, even an experienced scientific practitioner in this area is likely to find something new to engage them and expand their knowledge...In summary, an excellent and comprehensive book for beginners to the CP/PK area to acquaint themselves with the area of biologics (specifically mAb) CP/PKPD principles and for experienced CP/PK scientists for reference." (CPT: Pharmacometrics & Systems Pharmacology, March 2017)

Erscheint lt. Verlag 26.10.2015
Sprache englisch
Themenwelt Medizin / Pharmazie Gesundheitsfachberufe
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Chemie Organische Chemie
Technik
Schlagworte Biopharmaceuticals & Pharmaceutical Biotechnology • Biopharmazeutika u. Pharmazeutische Biotechnologie • Biowissenschaften • Cell & Molecular Biology • Chemie • Chemistry • Clinical Pharmacology & Therapeutics • Klinische Pharmakologie u. Therapie • Life Sciences • <p>Therapeutic proteins, therapeutic antibodies, monoclonal antibodies, ADME, translational PK/PD, pharmacokinetics and pharmacodynamics, biologic drugs, protein engineering, clinical pharmacology, target-driven pharmacokinetics, tumor effect compartment, brain effect compartment, vaccines, biosimilar, FcRn, disease status, ADCs, bispecifics, PBPK, physiologically based pharmacokinetic modelling, target-mediated drug disposition, immunogenicity</p> • Medical Science • Medizin • Pharmakokinetik • Pharmakologie • Zell- u. Molekularbiologie
ISBN-10 1-118-89874-5 / 1118898745
ISBN-13 978-1-118-89874-1 / 9781118898741
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Ohne DRM)

Digital Rights Management: ohne DRM
Dieses eBook enthält kein DRM oder Kopier­schutz. Eine Weiter­gabe an Dritte ist jedoch rechtlich nicht zulässig, weil Sie beim Kauf nur die Rechte an der persön­lichen Nutzung erwerben.

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür die kostenlose Software Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich